United Therapeutics Corporation is a pioneering publicly-traded biotech company founded in 1996 with a mission to develop innovative pharmaceutical therapies and technologies aimed at addressing the critical shortage of transplantable organs. The company is dedicated to improving the lives of patients suffering from rare and life-threatening diseases, such as pulmonary arterial hypertension and neuroblastoma, and has successfully brought six FDA-approved therapies to market. United Therapeutics is also at the forefront of creating manufactured organs to eliminate transplant waiting lists. With a commitment to bold innovation and a strong sense of purpose, the company fosters a dynamic work environment that encourages creativity and high-level performance, while offering a comprehensive benefits package to its employees.